Document is current
Any future updates will be listed below
-
Authors
Morella, Martino L.
Teneketzi, Martha
Ferraro, Federico
Moors, Tim E.
Boiten, Walter A.
Breve, John J. P.
Ingrassia, Angela M. T.
Geut, Hanneke
Pihlstrøm, Lasse
Udayar, Vinod
Bonifati, Vincenzo
van de Berg, Wilma D. J.
-
Funding
Funding for this research was provided by:
Stichting Parkinson Fonds (1880)
Michael J. Fox Foundation for Parkinson's Research (MJFF-022468)
Stichting Woelse Waard (ParkCode)
- License Information
-
More Information
Article History
Received: 30 March 2026
Accepted: 17 July 2026
First Online: 5 August 2026
Ethics
Competing interests: M.L.M., T.E.M., H.G., M.B. and V.U. are or were full-time employees of Roche/F. Hoffmann-La Roche Ltd. and may additionally hold Roche stock/stock options. W.D.J.vd.B. is a member of the scientific advisory board of Gain Therapeutics, a member of the scientific board of Alzheimer Nederland, and the president of the Dutch Parkinson scientists association. The other authors declare no competing interests.
